Download Files:
Decarboxy Moxifloxacin
$125 – $560
Products Details
Product Description
– Decarboxy Moxifloxacin (compound 8) is a decarboxylated compound of Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1].
Web ID
– HY-135398
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C20H24FN3O2
References
– [1]Marks KR, et al. Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones.Bioorg Med Chem Lett. 2011 Aug 1;21(15):4585-8.|[2]Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88.
CAS Number
– 1322062-57-6
Molecular Weight
– 357.42
SMILES
– O=C1C=CN(C2CC2)C3=C1C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology; Infection
Solubility
– 10 mM in DMSO
Target
– Bacterial
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
